Evidence map›Paper›PMID 36014809›Full record

ReviewNutrients2022

Fetal Brain Damage during Maternal COVID-19: Emerging Hypothesis, Mechanism, and Possible Mitigation through Maternal-Targeted Nutritional Supplementation.

Chiara Germano, Alessandro Messina, Elena Tavella, Raffaele Vitale, Vincenzo Avellis, Martina Barboni, Rossella Attini, Alberto Revelli, Paolo Zola, Paolo Manzoni and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Chiara GermanoDepartment of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", 13875 Ponderano, Italy.
Alessandro MessinaSant'Anna Hospital, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-6868-036X
Elena TavellaSant'Anna Hospital, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.
Raffaele VitaleSant'Anna Hospital, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.
Vincenzo AvellisSant'Anna Hospital, Department of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.
Martina BarboniSant'Anna Hospital, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
Rossella AttiniSant'Anna Hospital, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
Alberto RevelliSant'Anna Hospital, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-5797-3722
Paolo ZolaSant'Anna Hospital, Department of Surgical Sciences, University of Turin, 10126 Turin, Italy.
Paolo ManzoniDepartment of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", 13875 Ponderano, Italy.ORCID 0000-0003-1340-3493
Bianca MasturzoDepartment of Maternal, Neonatal and Infant Medicine, University Hospital "Degli Infermi", 13875 Ponderano, Italy.
Ospedale Sant'Anna · ITOspedale degli Infermi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent outbreak of the novel Coronavirus (SARS-CoV-2 or CoV-2) pandemic in 2019 and the risk of CoV-2 infection during pregnancy led the scientific community to investigate the potential negative effects of Coronavirus infection on pregnancy outcomes and fetal development. In particular, as CoV-2 neurotropism has been demonstrated in adults, recent studies suggested a possible risk of fetal brain damage and fetal brain development impairment, with consequent psychiatric manifestations in offspring of mothers affected by COronaVIrus Disease (COVID) during pregnancy. Through the understanding of CoV-2's pathogenesis and the pathways responsible for cell damage, along with the available data about neurotropic virus attitudes, different strategies have been suggested to lower the risk of neurologic disease in newborns. In this regard, the role of nutrition in mitigating fetal damages related to oxidative stress and the inflammatory environment during viral infection has been investigated, and arginine, n3PUFA, vitamins B1 and B9, choline, and flavonoids were found to be promising in and out of pregnancy. The aim of this review is to provide an overview of the current knowledge on the mechanism of fetal brain damage and the impact of nutrition in reducing inflammation related to worse neurological outcomes in the context of CoV-2 infections during pregnancy.

Indexed as

COVID-19Pregnancy Complications, InfectiousAdultBrainDietary SupplementsFemaleHumansInfant, NewbornInfectious Disease Transmission, VerticalPregnancySARS-CoV-2COVID-19fetal brain damagenutritionpregnancypreventionsupplementation in pregnancy

Identifiers

PMID36014809
PMCPMC9414753
OpenAlexW4291512743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.